Literature DB >> 17341188

The role of NKT cells in animal models of autoimmune hepatitis.

Gunther Dennert1, Fred Aswad.   

Abstract

NKT cells expressing invariant T-cell receptors are an abundant cell population in the mouse liver, and much evidence has been accumulating which shows that they play an important role in immune responses in this organ. In this review, the putative function of NKT cells in autoimmune hepatitis is discussed based on results from various mouse models. Features and functions of invariant NKT cells are summarized to set the stage to explain how these cells induce liver injury following the injection of mitogen concanavalin A or NKT-cell receptor ligand alpha-GalCer. Results are discussed which show that alcohol consumption can aggravate liver injury by NKT cells, whereas expression of a hepatitis C virus protein in hepatocytes can protect against injury. Hepatocytes, therefore, can modulate sensitivity to NKT-cell-mediated attack. Moreover, experiments that elucidate how NKT cells induce liver injury and how they are regulated to perform this function are discussed. Specific attention is given to the recently discovered role of purinergic receptor P2X7 in regulating NKT cells. The conclusion is drawn that the P2X7 receptor constitutes a sensor that senses purine-based danger signals, which trigger mechanisms that cause inhibition or stimulation of NKT-cell functions.

Entities:  

Mesh:

Year:  2006        PMID: 17341188     DOI: 10.1615/critrevimmunol.v26.i5.50

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  14 in total

Review 1.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

2.  Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.

Authors:  Hyo-Jung Kwon; Young-Suk Won; Ogyi Park; Dechun Feng; Bin Gao
Journal:  Hepatology       Date:  2014-01-21       Impact factor: 17.425

Review 3.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

4.  Invariant NKT cell activation induces neutrophil accumulation and hepatitis: opposite regulation by IL-4 and IFN-γ.

Authors:  Hua Wang; Dechun Feng; Ogyi Park; Shi Yin; Bin Gao
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

5.  Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunity.

Authors:  Dallas B Flies; Xue Han; Tomoe Higuchi; Linghua Zheng; Jingwei Sun; Jessica Jane Ye; Lieping Chen
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

6.  Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.

Authors:  Ogyi Park; Won-Il Jeong; Lei Wang; Hua Wang; Zhe-Xiong Lian; M Eric Gershwin; Bin Gao
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

7.  Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function.

Authors:  Jinwook Shin; Shang Wang; Wenhai Deng; Jinhong Wu; Jimin Gao; Xiao-Ping Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

8.  Personalized inherent randomness of the immune system is manifested by an individualized response to immune triggers and immunomodulatory therapies: a novel platform for designing personalized immunotherapies.

Authors:  Madi El-Haj; Dimitri Kanovitch; Yaron Ilan
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 9.  Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.

Authors:  Bin Gao; Svetlana Radaeva; Ogyi Park
Journal:  J Leukoc Biol       Date:  2009-09       Impact factor: 4.962

Review 10.  Purinergic signaling in liver disease.

Authors:  Byron P Vaughn; Simon C Robson; Maria Serena Longhi
Journal:  Dig Dis       Date:  2014-07-14       Impact factor: 2.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.